Live Updates: COVID-19 Cases
  • World 18,483,273
    World
    Confirmed: 18,483,273
    Active: 6,076,384
    Recovered: 11,708,582
    Death: 698,307
  • USA 4,863,077
    USA
    Confirmed: 4,863,077
    Active: 2,255,797
    Recovered: 2,448,305
    Death: 158,975
  • Brazil 2,751,665
    Brazil
    Confirmed: 2,751,665
    Active: 744,644
    Recovered: 1,912,319
    Death: 94,702
  • India 1,864,561
    India
    Confirmed: 1,864,561
    Active: 589,663
    Recovered: 1,235,841
    Death: 39,057
  • Russia 861,423
    Russia
    Confirmed: 861,423
    Active: 185,601
    Recovered: 661,471
    Death: 14,351
  • South Africa 516,862
    South Africa
    Confirmed: 516,862
    Active: 150,286
    Recovered: 358,037
    Death: 8,539
  • Mexico 443,813
    Mexico
    Confirmed: 443,813
    Active: 100,124
    Recovered: 295,677
    Death: 48,012
  • Peru 433,100
    Peru
    Confirmed: 433,100
    Active: 115,198
    Recovered: 298,091
    Death: 19,811
  • Chile 361,493
    Chile
    Confirmed: 361,493
    Active: 17,810
    Recovered: 333,976
    Death: 9,707
  • Spain 344,134
    Spain
    Confirmed: 344,134
    Active: 315,662
    Recovered: ?
    Death: 28,472
  • Iran 314,786
    Iran
    Confirmed: 314,786
    Active: 24,634
    Recovered: 272,535
    Death: 17,617
  • UK 305,623
    UK
    Confirmed: 305,623
    Active: 259,413
    Recovered: ?
    Death: 46,210
  • Pakistan 280,461
    Pakistan
    Confirmed: 280,461
    Active: 25,065
    Recovered: 249,397
    Death: 5,999
  • Saudi Arabia 280,093
    Saudi Arabia
    Confirmed: 280,093
    Active: 35,089
    Recovered: 242,055
    Death: 2,949
  • Italy 248,229
    Italy
    Confirmed: 248,229
    Active: 12,474
    Recovered: 200,589
    Death: 35,166
  • Bangladesh 244,020
    Bangladesh
    Confirmed: 244,020
    Active: 100,926
    Recovered: 139,860
    Death: 3,234
  • Turkey 233,851
    Turkey
    Confirmed: 233,851
    Active: 10,607
    Recovered: 217,497
    Death: 5,747
  • Germany 212,331
    Germany
    Confirmed: 212,331
    Active: 8,399
    Recovered: 194,700
    Death: 9,232
  • France 191,295
    France
    Confirmed: 191,295
    Active: 79,501
    Recovered: 81,500
    Death: 30,294
  • Canada 117,031
    Canada
    Confirmed: 117,031
    Active: 6,487
    Recovered: 101,597
    Death: 8,947
  • China 84,464
    China
    Confirmed: 84,464
    Active: 800
    Recovered: 79,030
    Death: 4,634
  • Netherlands 55,955
    Netherlands
    Confirmed: 55,955
    Active: 49,805
    Recovered: ?
    Death: 6,150
  • Australia 18,730
    Australia
    Confirmed: 18,730
    Active: 7,876
    Recovered: 10,622
    Death: 232
  • S. Korea 14,423
    S. Korea
    Confirmed: 14,423
    Active: 770
    Recovered: 13,352
    Death: 301
  • New Zealand 1,567
    New Zealand
    Confirmed: 1,567
    Active: 22
    Recovered: 1,523
    Death: 22

Health Ministry adds steroid dexamethasone in COVID-19 treatment protocol

Author at TechGenyz Health
Dexamethasone COVID-19 Medicine
Dexamethasone COVID-19 Medicine. Credit: @allan_crawshaw/twitter

An inexpensive, widely used steroid dexamethasone was included in the treatment protocols for COVID-19 patients in moderate to severe stages of illness among other therapeutic measures by the Union health ministry on Saturday.

The updated protocol includes the advice to use dexamethasone as an alternative choice to methylprednisolone for managing moderate to severe cases of COVID-19. The change has been made after considering the latest available evidence and expert consultation, the ministry said.

According to the revised ‘Clinical Management Protocols for COVID-19’, dexamethasone which is already used in treating lung infections besides in a wide range of conditions for its anti-inflammatory and immunosuppressant effects can be used as an alternative to methylprednisolone which already existed in the treatment guidelines.

The health ministry on June 13 had also allowed the use of antiviral drug Remdesivir for restricted emergency use and off-label application of tocilizumab, a drug that modifies the immune system or its functioning, and convalescent plasma for treating COVID-19 patients in the moderate stage of the illness as an investigational therapy.

It also recommended hydroxychloroquine in patients during the early course of the disease and not on critically ill patients.

The use of these drugs continues to be included in the revised treatment protocols under the ‘investigational therapy’.

The revised treatment protocols for moderate cases advised considering methylprednisolone 0.5 to 1 mg/kg or dexamethasone 0.1 to 0.2 mg/kg for three days, preferably within 48 hours of admission or if oxygen requirement is increasing and if inflammatory markers are increased. The duration of administration should be reviewed as per clinical response.

For patients having respiratory distress requiring mechanical ventilation, both non- invasive and invasive, the ministry said methylprednisolone 1 2mg/kg/day or dexamethasone 0.2 to 0.4 mg/kg per day should be considered for 5-7 days in two divided doses, if not given already.

“Note that a larger dose of glucocorticoid will delay the removal of coronavirus due to immunosuppressive effects,” the treatment protocols stated.

The revised treatment protocols were issued as India’s COVID-19 tally raced past the five-lakh mark on Saturday with the biggest single-day surge of 18,552 cases while the death toll climbed to 15,685 with 384 fatalities, the updated figure at 8 am showed.

According to WHO, the corticosteroid dexamethasone was tested in hospitalised patients with COVID-19 in the United Kingdom’s national clinical trial ‘RECOVERY’ and was found to have benefits for critically ill patients.

According to preliminary findings shared with WHO, for patients on ventilators, the treatment was shown to reduce mortality by about one-third, and for patients requiring only oxygen, mortality was cut by about one-fifth.

Career

Subscribe